- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07135557
Robot-Assisted Heart Surgery: R-One System Safety and Effectiveness Study for Coronary Artery Procedures
This groundbreaking clinical trial evaluated the R-One Vascular Interventional Navigation Control System, an innovative robotic technology designed to assist cardiologists during percutaneous coronary interventions (PCI). PCI procedures, commonly known as angioplasty with stenting, are minimally invasive treatments for blocked heart arteries that restore blood flow to the heart muscle. The study aimed to determine whether this robotic system could safely and effectively help doctors perform these life-saving procedures while potentially reducing radiation exposure to medical staff.
The research followed a prospective, multicenter design across several leading medical institutions in China, including Chinese PLA General Hospital and Peking University. A total of 145 adult patients between 18-80 years old with coronary artery disease requiring PCI treatment participated in the study. These patients had blockages in their heart arteries measuring 70% or more narrowing, with vessel diameters between 2.5-4.0 mm that could be treated with a single stent.
Patients were carefully screened to ensure their safety, excluding those with recent heart attacks, severe heart failure, pregnancy, bleeding disorders, or complex coronary anatomy that might not be suitable for robotic assistance. The study paid particular attention to patient protection, with extensive monitoring before, during, and after the procedure including blood tests, heart enzyme measurements, and electrocardiograms.
During the procedure, interventional cardiologists operated the R-One system from a protected cockpit, using joysticks to remotely control guidewires and catheters while watching real-time imaging on duplicate monitors. The system consisted of a robotic platform, radiation-proof screen, and disposable components designed to precisely manipulate the delicate instruments inside coronary arteries. All participating physicians received specialized training and had extensive experience with traditional PCI procedures.
The research team measured several important outcomes, including the clinical success rate (whether the procedure successfully opened the blocked artery without complications), technical success rate (whether the robotic system completed the procedure without needing to switch to manual operation), and various safety parameters. The study also evaluated radiation exposure to both patients and medical staff, procedure duration, contrast dye usage, and any adverse events.
For patients and caregivers considering robotic-assisted heart procedures, this technology represents a significant advancement in cardiac care. Robotic systems like R-One offer potential benefits including enhanced precision during delicate artery manipulations, reduced radiation exposure for medical teams who can operate from a protected cockpit, and possibly improved outcomes through more consistent instrument control. The technology may also reduce physical strain on interventional cardiologists during lengthy procedures, potentially contributing to better surgeon performance and patient safety.
This research is particularly important as medical technology continues to evolve toward less invasive, more precise treatments for heart disease. Coronary artery disease remains a leading cause of death worldwide, and innovations that improve the safety and effectiveness of treatments directly impact patient outcomes and quality of life. Robotic assistance in PCI procedures represents the frontier of interventional cardiology, blending human expertise with technological precision to create optimal treatment approaches.
The study included thorough follow-up care, with patients being monitored during their hospital stay (typically 3-5 days) and again at one month after the procedure. Researchers carefully tracked any complications, changes in medication, and overall recovery progress. This comprehensive approach ensured that both immediate and short-term effects of the robotic-assisted procedure were properly documented and analyzed.
For patients facing PCI procedures, understanding technological advancements like robotic assistance can help in making informed decisions about treatment options. While traditional manual PCI procedures have excellent safety records, robotic systems offer additional layers of precision and protection that may benefit certain patient populations. This research contributes valuable data to the growing body of evidence supporting the integration of robotics into routine cardiac care, potentially making complex heart procedures safer and more accessible to patients worldwide.
Upcoming Clinical Trials
-
NCT07814352RecruitingLeptomeningeal Disease (LMD)
-
NCT07814378Not yet recruitingAnemia | Pregnancy | Iron Deficiency Anaemia in Childbirth
-
NCT07814391Not yet recruitingPeri-Implantitis and Peri-implant Mucositis
-
NCT07814404Not yet recruiting
-
NCT07814417Not yet recruiting
-
NCT07814443Not yet recruiting
-
NCT07814456RecruitingInflammatory Bowel Disease | Ulcerative Colitis (UC)
-
NCT07814495Not yet recruiting
-
NCT07814508RecruitingDiabetes Mellitus | Diabetes Mellitus Type 2 | Sleep Quality | Ecological Momentary Assessment | Continuous Glucose Monitoring System | Diabetes (DM) | Diabetes Distress | Fear of Hypoglycemia | Diabetes Mellitus Type 1 | Glycemic Responses
-
NCT07814534Not yet recruitingParkinson Disease (PD)
-
NCT07814547RecruitingCarpal Tunnel Syndrome (CTS)